Hester Biosciences Limited has reported Consolidated financial results for the period ended June 30, 2024.
Financial Results (Q1 FY2025) - QoQ Comparison
The company has reported total income of Rs. 83.492 crores during the period ended June 30, 2024 as compared to Rs. 83.40 crores during the period ended March 31, 2024.
The company has posted net profit / (loss) of Rs. 6.336 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs. 4.950 crores for the period ended March 31, 2024.
The company has reported EPS of Rs. 8.80 for the period ended June 30, 2024 as compared to Rs. 7.52 for the period ended March 31, 2024.
Total Income | ₹ 83.492 crs | ₹83.40 crs | 0.11% |
Net Profit | ₹6.336 crs | ₹4.950 crs | 28.00% |
EPS | ₹8.80 | ₹7.52 | 17.02% |
Financial Results (Q1 FY2025) - YoY Comparison The company has reported total income of Rs. 83.492 crores during the period ended June 30, 2024 as compared to Rs.88.998 crores during the period ended June 30, 2023.
The company has posted net profit / (loss) of Rs.6.336 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs.5.869 crores for the period ended June 30, 2023.
The company has reported EPS of Rs.8.80 for the period ended June 30, 2024 as compared to Rs.7.89 for the period ended June 30, 2023.
Total Income | ₹ 83.492 crs | ₹88.998 crs | -6.19% |
Net Profit | ₹6.336 crs | ₹5.869 crs | 7.96% |
EPS | ₹8.80 | ₹7.89 | 11.53% |
Shares of Hester Biosciences Limited was last trading in BSE at Rs. 3067.90 as compared to the previous close of Rs. 3087.40. The total number of shares traded during the day was 3557 in over 867 trades.
The stock hit an intraday high of Rs. 3250.00 and intraday low of 2940.10. The net turnover during the day was Rs. 10830348.00.
Source : Equity Bulls
Keywords
HesterBiosciences
Q1FY25
FY2025
Q1FY2025
ResultUpdate